Identification of low density lipoprotein as a regulator of Fc receptor-mediated phagocytosis.
Optimal expression of the high-affinity Fc receptor for IgG (FcRI) by the human monocyte cell line U-937 requires the presence of low density lipoprotein (LDL), and neither cholesterol nor high density lipoprotein can provide the component necessary for optimal FcRI expression. Here we show that FcR-mediated phagocytosis also requires LDL. U-937 cells were cultured in medium containing interferon gamma and either fetal calf serum (FCS) or delipidated FCS (DLFCS). The phagocytosis of IgG-coated erythrocytes was measured by a colorimetric assay. U-937 cells cultured in DLFCS medium had less than 16% of the phagocytic activity of cells cultured in normal FCS medium. Phagocytosis of IgG-coated erythrocytes could be inhibited 85% by the addition of murine IgG2a myeloma protein (5 micrograms/ml). U-937 cells cultured in DLFCS medium supplemented with pure cholesterol in ethanol (10 micrograms/ml) had only 30% of the phagocytic activity of cells grown in FCS medium. Addition of very low density lipoprotein (0.2 mg of protein per ml) to DLFCS medium also failed to increase phagocytosis. However, the addition of LDL (0.2 mg of protein per ml) to DLFCS medium restored 90% of the phagocytic activity. Since neither pure cholesterol nor very low density lipoprotein restored normal phagocytic function to U-937 cells despite a normalization of cellular cholesterol content, the restoration of phagocytosis observed with LDL replacement cannot be explained by mere delivery of cholesterol by LDL. Thus, LDL is required for the expression of FcRI and FcR-mediated phagocytosis by U-937 cells and may be an important regulator of phagocytic activity of monocytes and macrophages in vivo.
Bigler
R D
RD
Department of Neoplastic Diseases, Hahnemann University School of Medicine, Philadelphia, PA 19102.
Khoo
M
M
Lund-Katz
S
S
Scerbo
L
L
Esfahani
M
M
D000818:Animals; D002417:Cattle; D002460:Cell Line; D002784:Cholesterol / Q000032:analysis / Q000494:pharmacology; D003470:Culture Media; D004912:Erythrocytes / Q000276:immunology; D006801:Humans; D007074:Immunoglobulin G; D007700:Kinetics; D008074:Lipoproteins / Q000494:pharmacology; D008077:Lipoproteins, LDL / Q000097:blood / Q000502:physiology*; D010587:Phagocytosis / Q000187:drug effects / Q000276:immunology*; D011961:Receptors, Fc / Q000187:drug effects / Q000502:physiology*
D003470:Culture Media; D007074:Immunoglobulin G; D008074:Lipoproteins; D008077:Lipoproteins, LDL; D011961:Receptors, Fc; D002784:Cholesterol